Even a company the size of TEVA does not spend 1.8 million dollars with the flick of a coin. There has to be a fundamental reason for it. Think about it, it might be enough money to hire someone like you for almost a year.
Tell your wife that Teva just spent 1.8 million Dollars on a bunch of empty injectors( and apparently keeps taking delivery of more as we post)that they plan to use in the not so far future. Either they ordered them because they are a bunch of nice guy's and want to look after their good friends at ATRS or else they might have ordered them out of a business decision that said we are going to need them soon and we want to be ready to go when we get the OK.
I'm not sure that the insiders are allowed to buy or sell at the moment. There is to much pending from the FDA.
They are only allowed to trade during quiet periods. Judging by the board this is not exactly a quiet period.
Deerfield hates ATRS.....that's why they bought all those shares a while ago, just like you bought 3,100 of them, they just picked up a few more.
"The Company has other products at various stages of development and approval. Antares is developing Vibex®Sumatriptan for the acute treatment of migraines and has begun commercial scale tooling and mold fabrication in anticipation of a potential approval and launch. The Company is currently conducting clinical studies of Vibex® QuickShot® Testosterone (“QS T”), for testosterone replacement therapy, and has also initiated manufacturing development work for QS M, a combination product for an undisclosed central nervous system indication. "
"a combination product for an undisclosed central nervous system indication."???Combination of what?
The whole Mylan CP was about the injector and it's not the first time that a Mylan's CP has been thrown out when they have tried going down the injector path. Mylan's own version II of their injector is not identical to their version I as FDA pointed out and VIBEX is already an FDA approved injector.
And if you think that after five years the FDA will come back and say.
Ahh Teva we forgot to mention this before, but it's the wrong colour......................
My guess was that they sold 300K injectors at 6$ each. The 1,8M was revenue not profit. There has been a lot of numbers thrown around about quantity of injectors. Mylan to my estimate is using about 8MM injectors/year.
AB-rated drugs are drugs that meet the necessary bioequivalence standards established by the Food and Drug Administration (FDA). A generic drug is considered bioequivalent to a brand-name drug if it contains the same active pharmaceutical ingredient as the branded drug, and if there is no significant difference in the formulation, quality, and effectiveness of the two drugs.
A pharmaceutical company seeking to market a generic version of a branded drug may file an Abbreviated New Drug Application (ANDA) with the FDA. In turn, the FDA will check whether or not the generic version submitted by the company meets the necessary bioequivalence standards. Upon approval, the FDA will rate this generic version as an AB-rated generic drug.
At the pharmacy, generic substitution is the process by which a generic equivalent is dispensed rather than the brand-name drug.
Many third party payers of prescription drugs (e.g., health insurance plans, Medicare and Medicaid programs) have adopted policies to encourage the substitution of the lower-priced AB-rated generic drugs for the higher-priced branded drugs, when an AB-rated generic drug is available.
On the other hand, there are non-AB rated drugs being dispensed by pharmacists every day. The non-AB rated products may not be substituted by the pharmacist without the permission from the doctor, because the non-AB rated drugs are considered therapeutic alternatives and therefore they are not generic substitutes.
If the pharmacist wants to change the patient's prescription to a non-AB rated drug, the pharmacist should get the patient's physician approval for the change. Nevertheless, a lot of pharmacists do not call the doctor to get the approval because calling the doctor to ask permission to dispense a non-AB rated drug depends on the pharmacy policy and on the state government regulation. On the other hand, it is worth noting that most doctors will allow the pharmacist to change the patient's prescription to a non-AB rated dr
How many posters here have multiple ID's. how many posters here delete their posts?
How do we know that you dont have another ID or me or anyone else?
How do you know who the ID that you guy's are discussing is the alternat ID that Ryman is suggesting?
How many ID's has Ryman got?
I can name a number of posters with multiple ID's.
This whole discussion is ridiculous.
YMB is an anonymous Message Board
Would you like to clarify please
Don't buy this stock at 1.99 because it's going to crash and burn..........
Buy this stock at 1.77 because it's going to crash and burn..........
What is the difference if in the end disaster looms?
So what do you think? The statement was:
"If you think Teva will get the AB rating, how can you call it anything else?"